A comprehensive market study of immunoassay has been conducted, involving the participation of 228 experienced end-users. The study profiled current practices, developments, trends and end-user plans over the next three years, as well as growth and opportunities across key life science, research and clinical sectors of these markets. These areas include growth in the use of immunoassay, immunoassay reader suppliers, immunoassay readers by model number, consumables suppliers, assay costs, immunoassay applications, multiplexing, immunoassay labels, immunoassay formats, relative assay costs areas, innovation and development needs, sample throughput and other areas. Its findings provide a wealth of market information on the current and developing used of immunoassay.


Research use of immunoassay:

  • Growth in end-user's immunoassay analysis now and anticipated in 3 years (±% change)
  • High-growth areas of immunoassay now and anticipated in 3 years (±% change)
  • Immunoassay reader suppliers now and anticipated in 3 years (±% change)
  • Immunoassay readers used now and anticipated in 3 years (±% change)
  • Immunoassay consumables suppliers now and anticipated in 3 years (±% change)
  • Three-year plans for the use of immunoassay
  • Relative consumables costs relating to the use of immunoassay
  • Immunoassay formats used now and anticipated in 3 years (±% change)
  • Applications of immunoassay now and anticipated in 3 years (±% change)
  • Immunoassay labels used now and anticipated in 3 years (±% change)
  • Immunoassay types used now and anticipated in 3 years (±% change)
  • Multiplexed immunoassay used now and anticipated in 3 years (±% change)
  • Innovation and development needs relating to the future use of immunoassay
  • Disease Biomarkers types, diseases, purposes, clinical utilities
  • Sample types analysed analysed now and anticipated in 3 years (±% change)
  • Diseases studied now and anticipated in 3 years (±% change)


Clinical use of immunoassay

  • Growth in end-user's immunoassay analysis now and anticipated in 3 years (±% change)
  • High-growth areas of immunoassay now and anticipated in 3 years (±% change)
  • Immunoassay reader suppliers now and anticipated in 3 years (±% change)
  • Immunoassay readers used now and anticipated in 3 years (±% change)
  • Immunoassay consumables suppliers now and anticipated in 3 years (±% change)
  • Three-year plans for the use of immunoassay
  • Relative consumables costs relating to the use of immunoassay
  • Immunoassay formats used now and anticipated in 3 years (±% change)
  • Applications of immunoassay now and anticipated in 3 years (±% change)
  • Immunoassay labels used now and anticipated in 3 years (±% change)
  • Immunoassay types used now and anticipated in 3 years (±% change)
  • Multiplexed immunoassay used now and anticipated in 3 years (±% change)
  • Innovation and development needs relating to the future use of immunoassay
  • Disease Biomarkers types, diseases, purposes, clinical utilities
  • Sample types analysed analysed now and anticipated in 3 years (±% change)
  • Diseases studied now and anticipated in 3 years (±% change)


Other areas:

  • Costs of sample analysis estimated by end users, using immunoassay
  • Average monthly throughput of samples by end users, using immunoassay
  • Countries and global regions
  • Organisation types
 
Immunoassays are biochemical test that measures the presence or concentration of an analyte by the use of antibodies. This technique is widely used in clinical and life science laboratories, in research, screening and routine tests in diagnostics and therapeutic monitoring. Immunoassay is also seeing new advances and its use continues to grow as new applications are developed. This report presents the findings of a new global study of immunoassay that profiled the laboratory use of this technique across research, life science and clinical sectors.